Follow ups of patients in AK1830 Phase II Studies
Phase 2
- Conditions
- osteoarthritis, chronic lumbar pain
- Registration Number
- JPRN-jRCT2031210566
- Lead Sponsor
- Kudo Katsuyasu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Patients who provided written informed consent to participate in the clinical study and who met all of the following criteria
[1] Patients who participated in the AK1830 Phase II Study and were deemed to require follow up.
[2] Patients who fully understand the contents of the study and are capable of providing informed consent
Exclusion Criteria
Patients who met any of the following criteria are to be excluded.
[1] Patients who have received their long-term safety outcomes in the AK1830 Phase II Study
[2] Patients deemed by the investigator or sub-investigator to be unsuitable for study participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method image evaluations
- Secondary Outcome Measures
Name Time Method